Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials

Sumit Kunwar, Khagendra Dahal, Sharan Sharma

Open source

DOI
10.1007/s00296-016-3480-9
Published
2016-04-22
Container
Rheumatology International
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00296-016-3480-9,
  title = {Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials},
  author = {Sumit Kunwar and Khagendra Dahal and Sharan Sharma},
  year = {2016},
  journal = {Rheumatology International},
  doi = {10.1007/s00296-016-3480-9},
  url = {https://doi.org/10.1007/s00296-016-3480-9}
}

RIS

TY  - JOUR
TI  - Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
AU  - Sumit Kunwar
AU  - Khagendra Dahal
AU  - Sharan Sharma
PY  - 2016
JO  - Rheumatology International
DO  - 10.1007/s00296-016-3480-9
UR  - https://doi.org/10.1007/s00296-016-3480-9
ER  - 

APA

Kunwar, S., Dahal, K., & Sharma, S. (2016). Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatology International. https://doi.org/10.1007/s00296-016-3480-9

Source records